Glickman Marc, Gheissari Ali, Money Samuel, Martin John, Ballard Jeffrey L
Virginia Vascular Associates, 880 Kempsville Rd, Suite 1000, Norfolk, VA 23502, USA.
Arch Surg. 2002 Mar;137(3):326-31; discussion 332. doi: 10.1001/archsurg.137.3.326.
An experimental polymeric sealant (CoSeal [Cohesion Technologies, Palo Alto, Calif]) provides equivalent anastomotic sealing to Gelfoam (Upjohn, Kalamazoo, Mich)/thrombin during surgical placement of prosthetic vascular grafts.
Randomized controlled trial.
Nine university-affiliated medical centers.
One hundred forty-eight patients scheduled for implantation of polytetrafluoroethylene grafts, mainly for infrainguinal revascularization procedures or the creation of dialysis access shunts, who were treated randomly with either an experimental intervention (n = 74) or control (n = 74).
Following polytetrafluoroethylene graft placement, anastomotic suture hole bleeding was treated intraoperatively in all control subjects with Gelfoam/thrombin. Subjects in the experimental group had the polymeric sealant applied directly to the suture lines without concomitant manual compression.
Primary treatment success was defined as the proportion of subjects in each group that achieved complete anastomotic sealing within 10 minutes. The proportion of subjects that achieved immediate sealing and the time required to fully inhibit suture hole bleeding also were compared between treatment groups.
Overall 10-minute sealing success was equivalent (86% vs 80%; P =.29) between experimental and control subjects, respectively. However, subjects treated with CoSeal achieved immediate anastomotic sealing at more than twice the rate of subjects treated with Gelfoam/thrombin (47% vs 20%; P<.001). Consequently, the median time needed to inhibit bleeding in control subjects was more than 10 times longer than for experimental subjects (16.5 seconds vs 189.0 seconds; P =.01). Strikingly similar findings for all comparisons were observed separately for subgroups of subjects having infrainguinal bypass grafting and for those undergoing placement of dialysis access shunts.
The experimental sealant offers equivalent anastomotic sealing performance compared with Gelfoam/thrombin, but it provides this desired effect in a significantly more rapid time frame.
一种实验性聚合物密封剂(CoSeal [科赫森技术公司,加利福尼亚州帕洛阿尔托])在人工血管移植物手术放置过程中,能提供与明胶海绵(优普强公司,密歇根州卡拉马祖)/凝血酶等效的吻合口密封效果。
随机对照试验。
九家大学附属医院。
148例计划植入聚四氟乙烯移植物的患者,主要用于腹股沟下血管重建手术或建立透析通路分流,随机接受实验性干预(n = 74)或对照(n = 74)治疗。
在植入聚四氟乙烯移植物后,所有对照组患者术中用明胶海绵/凝血酶治疗吻合口缝线孔出血。实验组患者将聚合物密封剂直接应用于缝线处,无需同时进行手动压迫。
主要治疗成功定义为每组中在10分钟内实现完全吻合口密封的患者比例。还比较了治疗组之间实现即刻密封的患者比例以及完全抑制缝线孔出血所需的时间。
实验组和对照组患者总体10分钟密封成功率相当(分别为86%和80%;P = 0.29)。然而,接受CoSeal治疗的患者实现即刻吻合口密封的比例是接受明胶海绵/凝血酶治疗患者的两倍多(47%对20%;P < 0.001)。因此,对照组患者抑制出血所需的中位时间比实验组患者长10倍以上(16.5秒对189.0秒;P = 0.01)。对于接受腹股沟下旁路移植术的患者亚组和接受透析通路分流放置的患者亚组,在所有比较中均观察到了惊人相似的结果。
与明胶海绵/凝血酶相比,实验性密封剂提供了等效的吻合口密封性能,但能在明显更短的时间内达到这种理想效果。